| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 339 |
| 1 | PREDNISONE | 229 |
| 2 | METHOTREXATE SODIUM | 160 |
| 3 | METHOTREXATE | 150 |
| 4 | ADALIMUMAB | 148 |
| 5 | DEXAMETHASONE | 132 |
| 6 | CARBOPLATIN | 125 |
| 7 | DEXAMETHASONE 1.5 MG | 125 |
| 8 | SOMATROPIN | 111 |
| 9 | CYCLOPHOSPHAMIDE | 108 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MECASERMIN | 16 | 0.0197 |
| 1 | FLUPHENAZINE HYDROCHLORIDE | 2 | 0.0174 |
| 2 | SOMAPACITAN-BECO | 3 | 0.0166 |
| 3 | TOFERSEN | 7 | 0.0123 |
| 4 | ACETAZOLAMIDE SODIUM | 66 | 0.0107 |
| 5 | SARECYCLINE HYDROCHLORIDE | 2 | 0.0100 |
| 6 | FLUCYTOSINE | 11 | 0.0078 |
| 7 | LEVOLEUCOVORIN INJECTION | 20 | 0.0065 |
| 8 | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 2 | 0.0063 |
| 9 | PEGCETACOPLAN | 12 | 0.0063 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 563 |
| 1 | Progestin [EPC] | 380 |
| 2 | Progestin-containing Intrauterine System [EPC] | 339 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 287 |
| 4 | Platinum-based Drug [EPC] | 215 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 158 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 151 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 136 |
| 8 | Alkylating Drug [EPC] | 129 |
| 9 | Proton Pump Inhibitor [EPC] | 123 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 11 | 0.0078 |
| 1 | Carbonic Anhydrase Inhibitor [EPC] | 67 | 0.0033 |
| 2 | Endoglycosidase [EPC] | 6 | 0.0032 |
| 3 | Diagnostic Dye [EPC] | 2 | 0.0031 |
| 4 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 3 | 0.0028 |
| 5 | Recombinant Human Growth Hormone [EPC] | 58 | 0.0026 |
| 6 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 3 | 0.0024 |
| 7 | Androgen [EPC] | 54 | 0.0020 |
| 8 | Methylating Agent [EPC] | 2 | 0.0019 |
| 9 | Lymphocyte Growth Factor [EPC] | 2 | 0.0016 |